regulatory
confidence high
sentiment negative
materiality 0.60
Pluri loses director Birger, triggering Nasdaq audit committee non-compliance with cure period
Pluri Inc.
- Doron Birger not re-elected at June 30 annual meeting; received 1,270,717 for, 2,720,350 against.
- Audit Committee now has only 2 independent directors, violating Nasdaq Rule 5605(c)(2)(A).
- Nasdaq granted cure period until earlier of next annual meeting or June 30, 2026.
- Company intends to appoint an additional independent director to regain compliance.
- Shareholders approved 2016 equity plan, advisory vote on exec comp every 2 years, and warrant exercise for Weinstein entity.